CELL 润色咨询

CELL

出版年份:1974 年文章数:5241 投稿命中率: 开通期刊会员,数据随心看

出版周期:Biweekly 自引率:2.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2021-01-14 张晓梅-Xiaomei Zhang

    别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。
    如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2022-09-05 monkeyjun

    审稿速度:24.0 | 投稿命中率:5.0
    偏重的研究方向:基因组学
    经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2022-10-08 12415e1cm11暂无昵称

    同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2022-08-29 632005764

    偏重的研究方向:单细胞测序
    经验分享:爱过。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2014-03-07 ninth9

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT.

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2019-02-06 hengyuanxiang

    请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    题目中是否需要对专有名词进行缩写?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2021-12-27 Mia

    审稿人一般更青睐于什么样的题目?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2021-11-07 第六号染色体

    针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水,可是文章的创新确实不一般,不是简单的堆数据量就能上的。 <br> 如果文章被cell拒搞也不要灰心,能给审稿意见就是大赚,能审cell的审稿人眼界确实不一般,给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:基因组学<br>经验分享:已经投了两周,还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇,我是来看看这期刊怎么样,毕竟同学很水,五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向:单细胞测序<br>经验分享:爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:发这个杂志是中国人的梦想,对创新要求很高,审稿回复很快,可发摘要询问,合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家,对Cell杂志的文章,想做comment或者letter,怎么投稿呢?杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=818, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=613, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文,我写了篇comment,经过1一个半月评审,编辑同意发布,不知道后续怎么操作啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=654, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576900, encodeId=3feb5e6900a7, content=你好 我想问下投稿后 全部作者都会收到确认邮件吗<span class="quote">yfkl 2018-09-18 发表::<br>悲剧,转战CSC</span><span class="quote">yfkl 2018-09-18 05:08:00 发表:<br>悲剧,转战CSC</span>, beContent=yfkl 2018-09-18 发表:: 悲剧,转战CSC, objectType=tool_impact_factor, channel=null, level=null, likeNumber=776, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dd02550425, createdName=1253efb8m87(暂无昵称), createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2019-09-25 1253efb8m87(暂无昵称)

    你好 我想问下投稿后 全部作者都会收到确认邮件吗yfkl 2018-09-18 发表::
    悲剧,转战CSC
    yfkl 2018-09-18 05:08:00 发表:
    悲剧,转战CSC

    yfkl 2018-09-18 发表:: 悲剧,转战CSC

    2

    展开2条回复
共71条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分